Gordon W. Dewald

Gordon W. Dewald's AcademicInfluence.com Rankings

Gordon W. Dewald

Economics

#3591

World Rank

#4064

Historical Rank

Monetary Economics

#109

World Rank

#113

Historical Rank

Macroeconomics

#337

World Rank

#357

Historical Rank

economics Degrees

Gordon W. Dewald

Biology

#13615

World Rank

#17169

Historical Rank

Biochemistry

#2398

World Rank

#2548

Historical Rank

biology Degrees

Download Badge

Economics
Biology

Why Is Gordon W. Dewald Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gordon W. Dewald's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion. (2006) (965)
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. (2005) (684)
Clinical and biologic implications of recurrent genomic aberrations in myeloma. (2003) (625)
The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes. (2005) (492)
The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. (1985) (426)
Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q. (2008) (401)
CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy. (2003) (372)
Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997. (2007) (366)
Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma. (2000) (342)
T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993). (2009) (327)
Genomic abnormalities in monoclonal gammopathy of undetermined significance. (2002) (325)
Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997. (2007) (314)
Anthracycline dose intensification in acute myeloid leukemia. (2009) (308)
Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients. (2002) (305)
Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia. (2006) (303)
Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. (1986) (293)
FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. (2004) (291)
The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma. (2003) (286)
A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group. (2004) (270)
Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993. (2009) (265)
Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia. (2006) (248)
A cytogenetic study of 53 human gliomas. (1989) (245)
Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995). (2004) (242)
Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B‐cell chronic lymphocytic leukaemia (2003) (234)
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma (2003) (227)
Analysis of clonal B‐cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B‐chronic lymphocytic leukaemia (2001) (223)
A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide (2009) (201)
Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia. (1998) (196)
Cytogenetic studies in 174 consecutive patients with preleukemic or myelodysplastic syndromes. (1985) (194)
Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia (2001) (193)
Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996). (2009) (187)
Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study. (2002) (186)
Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages. (1995) (186)
The Incidence and Anatomic Site Specificity of Chromosomal Translocations in Primary Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue (MALT Lymphoma) in North America (2006) (182)
The clinical significance of karyotype in acute myelogenous leukemia. (1989) (181)
CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential (2008) (160)
Chronic lymphocytic leukemia. (2010) (160)
Chromosome studies in 104 patients with polycythemia vera. (1991) (149)
Long-term survival in acute myelogenous leukemia: a second follow-up of the Fourth International Workshop on Chromosomes in Leukemia. (1994) (141)
FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature. (2006) (136)
Guidance for fluorescence in situ hybridization testing in hematologic disorders. (2007) (132)
A novel three-color, clone-specific fluorescence in situ hybridization procedure for monoclonal gammopathies. (1998) (130)
The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL. (1993) (130)
Chromosomal abnormalities and their clinical significance in acute lymphoblastic leukemia. Third International Workshop on Chromosomes in Leukemia. (1983) (130)
Physical mapping of a translocation breakpoint in neurofibromatosis. (1989) (129)
Adult B-Cell Lymphomas With Burkitt-Like Morphology Are Phenotypically and Genotypically Heterogeneous With Aggressive Clinical Behavior (2005) (128)
Relationship of patient survival and chromosome anomalies detected in metaphase and/or interphase cells at diagnosis of myeloma. (2005) (126)
Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience. (2000) (123)
Cytogenetic analysis of six renal oncocytomas and a chromophobe cell renal carcinoma. Evidence that -Y, -1 may be a characteristic anomaly in renal oncocytomas. (1992) (121)
Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemias. (2004) (115)
Diagnostic utility of fluorescence in situ hybridization in mantle‐cell lymphoma (2000) (114)
The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study. (2000) (113)
Long‐term survival of patients with acute myeloid leukemia (1997) (111)
Clinical-cytogenetic correlations in myelodysplasia (preleukemia). (1989) (108)
True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases. (1995) (106)
Mucosa-associated lymphoid tissue lymphomas with t(11;18)(q21;q21) and mucosa-associated lymphoid tissue lymphomas with aneuploidy develop along different pathogenetic pathways. (2002) (103)
Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma. (1999) (101)
A new method to extract nuclei from paraffin-embedded tissue to study lymphomas using interphase fluorescence in situ hybridization. (2002) (100)
Failure of inactivation of Duchenne dystrophy X‐chromosome in one of female identical twins (1977) (97)
Female phenotype and multiple abnormalities in sibs with a Y chromosome and partial X chromosome duplication: H--Y antigen and Xg blood group findings. (1980) (97)
Frequent occurrence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma (1990) (96)
Cases of neurofibromatosis with rearrangements of chromosome 17 involving band 17q11.2 (1987) (95)
Chromosomally abnormal clones and nonrandom telomeric translocations in cardiac myxomas. (1987) (95)
The 5q- syndrome: a single-institution study of 43 consecutive patients. (1993) (94)
Clinical characteristics and prognosis of 50 patients with a myeloproliferative syndrome and deletion of part of the long arm of chromosome 5. (1985) (93)
Hematologic manifestations associated with deletions of the long arm of chromosome 20. (1984) (93)
Preclinical validation of fluorescence in situ hybridization assays for clinical practice (2006) (92)
Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia. (2003) (87)
Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study. (2003) (86)
Hematologic disorders associated with deletions of chromosome 20q: a clinicopathologic study of 107 patients. (1996) (84)
A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia. (1998) (82)
Primary pulmonary MALT lymphomas show frequent and heterogeneous cytogenetic abnormalities, including aneuploidy and translocations involving API2 and MALT1 and IGH and MALT1 (2004) (80)
Clinical laboratory assays for HER-2/neu amplification and overexpression: quality assurance, standardization, and proficiency testing. (2002) (80)
Rothmund‐Thomson syndrome in siblings: evidence for acquired in vivo mosaicism (1996) (78)
Culturing and robotic harvesting of bone marrow, lymph nodes, peripheral blood, fibroblasts, and solid tumors with in situ techniques. (1988) (76)
Phase 2 study of lenalidomide in transfusion-dependent , low-risk , and intermediate-1 – risk myelodysplastic syndromes with karyotypes other than deletion 5 q (2007) (76)
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission. (2007) (75)
Karyotype evolution on fluorescent in situ hybridization analysis is associated with short survival in patients with chronic lymphocytic leukemia and is related to CD49d expression. (2008) (74)
BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients. (1996) (74)
The efficacy of direct, 24-hour culture, and mitotic synchronization methods for cytogenetic analysis of bone marrow in neoplastic hematologic disorders. (1985) (71)
A surrogate marker profile for PML/RARα expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes (2004) (71)
Ph1-negative chronic granulocytic leukemia: a nonentity. (1986) (71)
Acute monocytic leukemia (French-American-British classification M5) does not have a worse prognosis than other subtypes of acute myeloid leukemia: a report from the Eastern Cooperative Oncology Group. (2004) (68)
Primary myelodysplastic syndrome with normal cytogenetics: utility of 'FISH panel testing' and M-FISH. (2002) (66)
Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia. (2009) (65)
Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia. (2002) (65)
New highly sensitive fluorescence in situ hybridization method to detect PML/RARA fusion in acute promyelocytic leukemia. (2003) (65)
Characterization of a translocation within the von Recklinghausen neurofibromatosis region of chromosome 17. (1989) (64)
Autologous transplantation gives encouraging results for young adults with favorable-risk acute myeloid leukemia, but is not improved with gemtuzumab ozogamicin. (2011) (64)
Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia? (2003) (63)
Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma (2003) (61)
The JAK 2 V 617 F activating tyrosine kinase mutation is an infrequent event in both “ atypical ” myeloproliferative disorders and myelodysplastic syndromes (2005) (61)
Acute leukemia with abnormal thrombopoiesis and inversions of chromosome 3. (1989) (59)
Chronic myeloid leukemia: current application of cytogenetics and molecular testing for diagnosis and treatment. (2005) (59)
Clinical phenotype associated with terminal 2q37 deletion (1995) (57)
Fluorescence in situ hybridization with X and Y chromosome probes for cytogenetic studies on bone marrow cells after opposite sex transplantation. (1993) (57)
Usefulness of chromosome examination in the diagnosis of malignant pleural effusions. (1976) (57)
Chromosome studies in 17 patients with the Sézary syndrome (1985) (56)
Chromosomal abnormalities in systemic amyloidosis (1998) (56)
Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group (2010) (55)
Effect of recombinant gamma interferon on chronic myelogenous leukemia bone marrow progenitors. (1987) (54)
Atypical BCR and ABL D-FISH patterns in chronic myeloid leukemia and their possible role in therapy. (1999) (53)
A multicenter investigation with interphase fluorescence in situ hybridization using X- and Y-chromosome probes. (1998) (53)
Dysregulated angiogenesis in B-chronic lymphocytic leukemia: Morphologic, immunohistochemical, and flow cytometric evidence (2008) (52)
A multicenter investigation with D-FISH BCR/ABL1 probes. (2000) (50)
A possible specific chromosome marker for monocytic leukemia: three more patients with t(9;11)(p22;q24) and another with t(11;17)(q24;q21), each with acute monoblastic leukemia. (1983) (50)
Twenty-six patients with hematologic disorders and X chromosome abnormalities. Frequent idic(X)(q13) chromosomes and Xq13 anomalies associated with pathologic ringed sideroblasts. (1989) (50)
Prognostic value of cytogenetic analysis in human cerebral astrocytomas (1992) (49)
A genetic review of complete and partial hydatidiform moles and nonmolar triploidy. (1992) (47)
Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia (1986) (46)
Three patients with structurally abnormal X chromosomes, each with Xq13 breakpoints and a history of idiopathic acquired sideroblastic anemia. (1982) (46)
Der(6)t(1;6)(q21–23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasia (2005) (45)
JAK2V617F and leukemic transformation in myelofibrosis with myeloid metaplasia (2006) (44)
Origin of chi46,XX/46,XY chimerism in a human true hermaphrodite. (1980) (44)
Deletions of chromosome 13 in malignant hematologic disorders. (1985) (44)
HER-2 fluorescence in situ hybridization: results from the survey program of the College of American Pathologists. (2006) (44)
Cytogenetic heteromorphisms: survey results and reporting practices of giemsa-band regions that we have pondered for years. (2006) (44)
Chronic lymphocytic leukemia FISH panel: impact on diagnosis. (2007) (43)
Possible cytogenetic distinction between lymphoid and myeloid blast crisis in chronic granulocytic leukemia (1988) (43)
The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial (2013) (42)
Prenatal detection of aneuploidy by directly labeled multicolored probes and interphase fluorescence in situ hybridization. (1998) (42)
Deficiency of chromosome 8p21.1----8pter: case report and review of the literature. (1985) (42)
Fludarabine and Cyclophosphamide Produces a Higher Complete Response Rate and More Durable Remissions than Fludarabine in Patients with Previously Untreated CLL: Intergroup Trial E2997. (2004) (42)
Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997. (2011) (41)
Chromosome abnormalities in malignant hematologic disorders. (1985) (40)
Unbalanced 1;7 translocation and therapy induced hematologic disorders: A possible relationship (1986) (39)
Dual color fluorescence in situ hybridization to investigate aneuploidy in sperm from 33 normal males and a man with a t(2;4;8)(q23;q27;p21) (1994) (39)
A tdic(5;15)(p31;p11) chromosome showing variation for constriction in the centromeric regions in a patient with the cri du chat syndrome. (1979) (39)
T-lymphocytes with 7;14 translocations: frequency of occurrence, breakpoints, and clinical and biological significance. (1986) (38)
Hematologic and cytogenetic (CTG) response to lenalidomide (CC-5013) in patients with transfusion-dependent (TD) myelodysplastic syndrome (MDS) and chromosome 5q31.1 deletion: Results of the multicenter MDS-003 Study (2005) (38)
Frequency and photographs of HGM11 chromosome anomalies in bone marrow samples from 3,996 patients with malignant hematologic neoplasms. (1993) (38)
A diploid‐triploid human mosaic with cytogenetic evidence of double fertilization (1975) (38)
Acute myeloid leukemia with minimal differentiation. A multiple parameter study. (1998) (37)
Hematologic disorders in 13 patients with acquired trisomy 21 and 13 individuals with Down syndrome. (2005) (37)
Detection of RB1 deletions by fluorescence in situ hybridization in malignant hematologic disorders. (1998) (35)
Loss of TP53 is due to rearrangements involving chromosome region 17p10∼p12 in chronic lymphocytic leukemia (2006) (35)
Optimizing preparation of normal dendritic cells and bcr-abl+ mature dendritic cells derived from immunomagnetically purified CD14+ cells. (2000) (35)
The erythroid leukemias: a comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease. (1998) (34)
Primer on medical genomics part I: History of genetics and sequencing of the human genome. (2002) (34)
Cytogenetic analyses on giant-cell tumors of bone. (1989) (33)
Very Poor Survival of Patients with AML Who Relapse after Achieving a First Complete Remission: The Eastern Cooperative Oncology Group Experience. (2005) (32)
Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: Clinicopathologic correlations and new insights from the prelenalidomide era (2008) (32)
Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity (2001) (31)
Replication patterns of three isodicentric X chromosomes and an X isochromosome in human lymphocytes. (1978) (31)
Comparison of peripheral blood interphase cytogenetics with bone marrow karyotype analysis in myelofibrosis with myeloid metaplasia (2001) (30)
Correlation of three methods of measuring cytogenetic response in chronic myelocytic leukemia. (2002) (30)
Cytogenetic abnormalities in multiple myeloma. (1999) (29)
Recurrent Miscarriages: Cytogenetic Causes and Genetic Counseling of Affected Families (1986) (29)
Fluorescent in situ hybridization studies of lymphocytes and neutrophils in chronic granulocytic leukemia. (1995) (29)
Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemia. (2005) (29)
Primer on medical genomics part II: Background principles and methods in molecular genetics. (2002) (29)
C028 Cytogenetic response to lenalidomide is associated with improved survival in patients with chromosome 5q deletion (2007) (29)
Efficacy of fluorescence in situ hybridization for detecting PML/RARA gene fusion in treated and untreated acute promyelocytic leukemia. (1994) (29)
Prevalence, breakpoint distribution, and clinical correlates of t(5;12). (2004) (29)
Xp22.3 microdeletion syndrome with microphthalmia, sclerocornea, linear skin defects, and congenital heart defects. (1992) (29)
Molecular Classification Improves Risk Assessment in Adult BCR-ABL1-negative B-ALL. (2021) (28)
Combination Chemotherapy with Pentostatin, Cyclophosphamide and Rituximab Induces High Rate of Remissions Including Complete Responses and Achievement of Minimal Residual Disease in Previously Untreated B-Chronic Lymphocytic Leukemia. (2004) (27)
Cytogenetic and molecular genetic methods for diagnosis and treatment response in chronic granulocytic leukemia. (1997) (25)
Interphase FISH studies of chronic myeloid leukemia. (2002) (25)
Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia? (2012) (25)
Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an eastern cooperative oncology group trial (E4995) (2005) (25)
Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients. (2008) (25)
Form of 15q proximal duplication appears to be a normal euchromatic variant. (1994) (24)
Fluorescence in situ hybridization to visualize genetic abnormalities in interphase cells of acinar cell carcinoma, ductal adenocarcinoma, and islet cell carcinoma of the pancreas. (2009) (24)
DNA fluorescent probes for diagnosis of velocardiofacial and related syndromes. (1995) (24)
Application of fluorescent in situ hybridization with X and Y chromosome specific probes to buccal smear analysis. (1996) (24)
Exclusion of the HLA locus from a large portion of the long arm of chromosome 6. (1977) (23)
Sister chromatid exchanges in Bloom's syndrome. (1978) (23)
Cytogenetic abnormalities can change during the course of the disease process in chronic lymphocytic leukemia. (2006) (23)
Proficiency testing for laboratories performing fluorescence in situ hybridization with chromosome-specific DNA probes. (2002) (23)
Phase III Prospective Randomized Trial of EPO with or without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes (MDS): Results of the ECOG- CLSG Trial(E1996). (2004) (23)
JAK2(V617F) and leukemic transformation in myelofibrosis with myeloid metaplasia. (2006) (22)
Method for sequential staining of GTL-banded metaphases with fluorescent-labeled chromosome-specific paint probes. (1993) (22)
Duplication of 7q31.2----7qter and deficiency of 18qter: report of two patients and literature review. (1986) (22)
Karyotypic analysis in primary myelodysplastic syndromes. (1993) (22)
Standardization of fluorescence in situ hybridization studies on chronic lymphocytic leukemia (CLL) blood and marrow cells by the CLL Research Consortium. (2010) (22)
Identification of a small supernumerary ring chromosome 8 by fluorescent in situ hybridization in a child with developmental delay and minor anomalies. (1994) (21)
T‐cell chronic lymphocytic leukemia with a helper/inducer membrane phenotype: A distinct clinicopathologic subtype with a poor prognosis (1986) (21)
A novel tricolor, dual-fusion fluorescence in situ hybridization method to detect BCR/ABL fusion in cells with t(9;22)(q34;q11.2) associated with deletion of DNA on the derivative chromosome 9 in chronic myelocytic leukemia. (2004) (21)
Primer on medical genomics. Part XI: Visualizing human chromosomes. (2004) (21)
A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia. (2006) (20)
Erythrophagocytic acute lymphocytic leukemia with B-cell markers and with a 20q- chromosome abnormality. (1984) (20)
Hereditary neuropathy with liability to pressure palsies and inherited brachial plexus neuropathy--two genetically distinct disorders. (1995) (20)
Cytogenetics of chronic myeloproliferative disorders and related myelodysplastic syndromes. (2003) (20)
Duplication of part of chromosome 1q: clinical report and review of literature. (1984) (20)
Cytogenetic studies in 11 patients with small cell carcinoma of the lung. (1989) (20)
Long Term Clinical Benefit of Lenalidomide (Revlimid) Treatment in Patients with Myelodysplastic Syndrome without Del 5q Cytogenetic Abnormalities. (2006) (20)
Utility of interphase FISH to stratify patients into cytogenetic risk categories at diagnosis of AML in an Eastern Cooperative Oncology Group (ECOG) clinical trial (E1900). (2007) (20)
Normal cytogenetic values for bone marrow based on studies of bone marrow transplant donors. (1991) (20)
Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic Trials. (2017) (18)
Primary myelofibrosis is the most frequent myeloproliferative neoplasm associated with del(5q): clinicopathologic comparison of del(5q)-positive and -negative cases. (2008) (18)
A Cytogenetic Method for Mailed-in Bone Marrow Specimens for the Study of Hematologic Disorders (1982) (18)
Pseudomosaicism, true mosaicism, and maternal cell contamination in amniotic fluid processed with in situ culture and robotic harvesting (1992) (17)
Loss of TP53 is due to rearrangements involving chromosome region 17p10 approximately p12 in chronic lymphocytic leukemia. (2006) (17)
Cytogenetic findings in 21 cases of peripheral T‐Cell lymphoma (1990) (17)
Chromosomal studies in cryptorchidism. (1977) (16)
Prognostic implications of additional chromosome abnormalities among patients with de novo acute promyelocytic leukemia with t(15;17) (2012) (16)
Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemia. (2006) (16)
Chromosome abnormalities in the myeloproliferative disorders. (1995) (16)
The Prognostic Significance of Trisomy 8 in Patients With Acute Myeloid Leukemia (2002) (16)
Chromosomes in a patient with the Sezary syndrome. (1974) (16)
Low expression of the myeloid differentiation antigen CD65s, a feature of poorly differentiated AML in older adults: study of 711 patients enrolled in ECOG trials (2003) (16)
Sex Chromosome Anomalies Associated with Premature Gonadal Failure (1983) (16)
Duplication of 7p: further delineation of the phenotype and restriction of the critical region to the distal part of the short arm. (1996) (16)
Metaphase cells with normal G-bands have cryptic interstitial deletions in 13q14 detectable by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia. (2006) (15)
Long-Term Clinical Benefit of Lenalidomide (Revlimid) Treatment in Patients with Myelodysplastic Syndrome and Chromosome Deletion 5q. (2006) (15)
Duplication of 7p: Further delineation of the phenotype and restriction of the critical region to the distal part of the short arm (1996) (14)
Chromosome 5q deletion: specific diagnoses and cytogenetic details among 358 consecutive cases from a single institution. (2008) (14)
Uniparental disomy in congenital disorders: a prospective study. (1995) (14)
Absence of chromosome fragility at 19q13.3 in patients with myotonic dystrophy. (1993) (14)
Meiotic Behavior and Fertility Interrelationship in Andropogon scoparius and A. gerardi (1974) (13)
Efficacy of conventional cytogenetics and FISH for EGR1 to detect deletion 5q in hematological disorders and to assess response to treatment with Lenalidomide. (2006) (13)
Cytogenetic diagnosis of malignant pleural effusions: culture methods to supplement direct preparations in diagnosis. (1982) (13)
The ( 11 ; 14 ) ( q 13 ; q 32 ) Translocation in Multiple Myeloma A Morphologic and Immunohistochemical Study (2002) (13)
Secondary Acute Myelogenous Leukemia with MLL Gene Rearrangement Following Radioimmunotherapy (RAIT) for Non-Hodgkin's Lymphoma (2002) (12)
Surface immunoglobulin positive lymphoblastic leukemia in adults; a genetic spectrum (2006) (12)
Implications for the Use of Monoclonal Antibodies in Future Adult ALL Trials: Analysis of Antigen Expression in 505 B-Lineage (B-Lin) ALL Patients (pts) on the MRC UKALLXII/ECOG2993 Intergroup Trial. (2008) (12)
Cytogenetic guidelines for fragile X studies tested in routine practice. (1992) (12)
Fluorescent in situ hybridization: use of whole chromosome paint probes to identify unbalanced chromosome translocations. (1992) (12)
Trisomy 9 in hematologic disorders: possible association with primary thrombocytosis. (1987) (11)
Pilot studies for proficiency testing using fluorescence in situ hybridization with chromosome-specific DNA probes: a College of American Pathologists/American College of Medical Genetics Program. (1997) (11)
Molecular cytogenetic studies for hematological malignancies. (2004) (11)
Philadelphia chromosome mosaicism at diagnosis in chronic myeloid leukemia: Clinical correlates and effect on imatinib mesylate treatment outcome (2007) (11)
International Working Group on MDS cytogenetics: October 2007 meeting report. (2008) (11)
Detection of hyperdiploid malignant cells in pleural effusions with chromosome-specific probes and fluorescence in situ hybridization. (1996) (11)
Toward quality assurance for metaphase FISH: a multi-center experience. (1996) (11)
Efficacy of calcium ionophore A23187 oocyte activation for generating parthenotes for human embryo research (1996) (10)
A computer-based videodensitometric system for studying banded human chromosomes illustrated by the analysis of the normal morphology of chromosome 18. (1977) (10)
Cytogenetic studies in malignant lymphoma: Possible role in staging studies (1980) (10)
FISH Demonstrates Treatment-Related Chromosome Damage in Myeloid but not Plasma Cells in Primary Systemic Amyloidosis (2000) (10)
Frequency, hematopathology, and detection of a new isodicentric variant of deletion 20q. (2006) (10)
Chromosome analysis of cryopreserved cells. (1990) (9)
Cytogenetic and FISH studies in myelodysplasia, acute myeloid leukemia, chronic lymphocytic leukemia and lymphoma. (2002) (9)
Extensive analysis of mosaicism in a case of Turner syndrome: the experience of 287 cytogenetic laboratories. College of American Pathologists/American College of Medical Genetics Cytogenetics Resource Committee. (1999) (9)
Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997 (2015) (9)
Chromosome studies in scleroderma with consideration of anticentromere antibody status and assessment of possible in vitro clastogenic activity. (1986) (8)
Trisomy 8 in acute myeloid leukemia (2000) (8)
Mitomycin C chromosome stress test to identify hypersensitivity to bifunctional alkylating agents in patients with Fanconi anemia or aplastic anemia. (1997) (8)
Outcome of Treatment with Fludarabine Versus Fludarabine and Cyclophosphamide in Chronic Lymphocytic Leukemia (CLL) Is Adversely Impacted by High Risk Genetic Features: Results from ECOG 2997. (2004) (8)
154 chromosome anomalies in hematologic malignancies. (2000) (7)
Gene Dosage of the Cell Cycle Regulatory Phosphatases Cdc25C and PP2A Determines Sensitivity to Lenalidomide in del(5q) MDS. (2007) (7)
Chronic granulocytic leukemia: recent information on pathogenesis, diagnosis, and disease monitoring. (1997) (7)
Fluorescence in situ hybridization studies of interphase nuclei for assessing response to therapy in patients with chronic myeloid leukemia. (1998) (7)
Detection of Mosaicism in amniotic fluid cultures: A CYT02000 collaborative study (1999) (7)
Proficiency testing in clinical cytogenetics. A 6-year experience with photographs, fixed cells, and fresh blood. (1993) (7)
Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia (B-ALL) Patients (pts) From the International UKALLXII/E2993 Trial: No Difference In Results Between B Cell Immunophenotypic Subgroups (2010) (7)
Hematologic malignancies, critical genes and representative pictures for 166 chromosome anomalies. (2004) (6)
Peripheral blood cytogenetic studies in myelofibrosis: overall yield and comparison with bone marrow cytogenetic studies. (2008) (6)
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia (2007) (6)
Ecological Aspects of Some Bluestem Communities in the Red River Valley (1973) (6)
Acute promyelocytic leukemia with t(15;16;17;19) and unusual fluorescence in situ hybridization pattern with PML and RARA probes. (1996) (6)
As currently formulated, ISCN FISH nomenclature make it not practical for use in clinical test reports or cytogenetic databases (2003) (6)
Multiple unrelated clonal abnormalities in host bone marrow cells after allogeneic stem cell transplantation. (2004) (6)
Familial pericentric and paracentric inversions of chromosome 1 (1988) (6)
The thrombin receptor gene is centromeric to the common proximal breakpoint in patients with the 5q− syndrome: identification of a previously unrecognized chromosome 5 inversion (1996) (6)
Using Controls for Molecular Cytogenetic Testing in Clinical Practice. (2005) (6)
Impact of Cytogenetics on Outcome of Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation for Adults with AML. (2004) (5)
Erratum: A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide (Proceedings of the National Academy of Sciences of the United States of America (2009) 106:31 (12974-12979) DOI: 10.1073/pnas.0811267106) (2013) (5)
Acute lymphocytic leukemia: Correlation of clinical features with immunocytochemical classification (1987) (5)
Isochromosome (X)(p10) in hematologic disorders: FISH study of 14 new cases show three types of centromere signal patterns. (2007) (5)
Oncogene expression in T-cell lymphoproliferative disorders. (1988) (5)
Toward quality assurance for metaphase FISH: a multicenter experience. (1996) (5)
Inverted duplication involving alpha satellite DNA resulting in a C-negative-band in the qh region of chromosome 16. (1993) (4)
Alemtuzumab and Rituximab for Therapy of Patents with Early Stage High Risk CLL: Report of a Planned Interim Analysis. (2006) (4)
Problems with ISCN FISH Nomenclature make it not practical for use in clinical test reports or cytogenetic databases [corrected]. (2003) (4)
Increased Incidence of Therapy Related Myeloid Neoplasia (t-MN) After Initial Therapy for CLL with Fludarabine-Cyclophosphamide (FC) Vs Fludarabine (F): Long-Term Follow-up of US Intergroup Study E2997 (2010) (4)
Cytogenetic studies on 12 thyroid carcinomas (1989) (4)
A randomized trial of anthracycline dose intensification during induction of younger patients with acute myeloid leukemia: Results of Eastern Cooperative Oncology Group study E1900. (2009) (4)
Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900 (2018) (4)
Clinical Significance of Homozygous D13S319 Deletion in B-Cell Chronic Lymphocytic Leukemia (B-CLL). (2004) (3)
Low Frequency of Treatment-Related Myelodysplastic Syndromes (t-MDS) after Autotransplants (AT) for Multiple Myeloma (MM), Especially If AT Is Applied Early during Treatment. (2005) (3)
Outcome in Philadelphia Chromosome Positive (Ph+) Adult ALL Patients (Pts) May Be More Determined by CD25 Expression Than by Ph Status Per Se. (2008) (3)
Frequency of Clonal Evolution by FISH in Untreated, Early Stage Patients with CLL: A Prospective, Longitudinal Study with Long Clinical Follow-Up. (2005) (3)
O-38 Hematologic and cytogenetic (CTG) response to lenalidomide (CC-5013; revlimid) in transfusion dependent (TD) MDS with chromosome 5Q31.1 deletion: Results of the multicenter MDS-003 study* (2005) (3)
Will a Peripheral Blood (PB) Sample Yield the Same Diagnostic and Prognostic Cytogenetic Data as the Concomitant Bone Marrow (BM) In Myelodysplasia? An International Study Comparing Cytogenetics and Interphase FISH Using Parallel PB and BM Samples (2010) (3)
The clinical spectrum of adult acute myeloid leukemia (AML) associated with core binding factor (CBF) translocations (2005) (3)
P-121 Lenalidomide (CC-5013; revlimid™)-inducedred blood cell (RBC) transfusion-independence (TI) responses in low-/INT-1-risk patients with myelodysplastic syndromes (MDS): Results of the multicenter mds 002 study (2005) (3)
Subspecialty Clinics: Hematology (1992) (2)
Peripheral Blood Cytogenetic Studies in Hematological Neoplasms: Predictors of Obtaining Metaphases for Analysis. (2007) (2)
Clinical, Laboratory, and Treatment Outcome Characteristics of Chronic Lymphocytic Leukemia (CLL) Patients with p53 Mutations or del(17p) Enrolled on a Prospective Phase III Clinical Trial: Short Progression Free Survival, Irrespective of Fludarabine-Based Treatment Used. (2004) (2)
Activating FLT 3 Mutations in CD 117 / KIT Positive T-Cell Acute Lymphoblastic Leukemias (2004) (2)
Erratum: Problems with ISCN FISH Nomenclature make it not practical for use in clinical test reports or cytogenetics databases (Genetics in Medicine (2003) 5 (370-377)) (2003) (2)
Theoretical proportion of trisomy 21 originating in meiosis I and II. (1987) (2)
Proficiency testing in clinical cytogenetics. The 1986 experience of the College of American Pathologists. (1988) (2)
Clonal cytogenetic anomalies suggestive of a myelodysplastic syndrome in patients with morphologically normal bone marrow aspirates (2000) (2)
Congenital deformities and chromosomal disorders: maternal versus paternal age. (1977) (2)
Reviewer Acknowledgment (2013) (2)
Trisomy 13 in a 16-year-old boy (1992) (1)
Prognostic Importance of CD49d Expression in Chronic Lymphocytic Leukemia. (2006) (1)
syndrome in both "atypical" myeloproliferative disorders and the myelodysplastic The JAK2 V617F activating tyrosine kinase mutation is an infrequent event (2013) (1)
Consistent abnormalities of chromosomes 1 and 22 in human nervous system tumors (1985) (1)
randomized prospective trial (UKALL XII/ECOG 2993) immunophenotype, cytogenetics, and outcome from the large T-cell acute lymphoblastic leukemia in adults: clinical features, (2013) (1)
Standard Consolidation/Maintenance Chemotherapy Is Consistently Superior to a Single Autologous Transplant for Adult Patients with Acute Lymphoblastic Leukemia: Results of the International ALL Trial (MRC UKALL XII/ECOG E2993) (2008) (1)
Hematology meeting, New Orleans, LA, December 1999. Group experience : Presented in part at the American Society of Acute megakaryocytic leukemia: the Eastern Cooperative Oncology (2013) (1)
Detection of 46,XX male by Y-specific whole chromosome paint probe. (1994) (1)
Familial Chronic Lymphocytic Leukemia(CLL): The Mayo Clinic Experience. (2004) (1)
Gemtuzumab-ozogamicin (GO; Mylotarg®) as part of consolidation therapy for AML before autograft: Low incidence of hepatic veno-occlusive disease (2005) (1)
Methylation of the Tumor Suppressor Gene PTPRO (Receptor-Type Protein Tyrosine Phosphatase) Is Associated with Expression of Important Apoptosis-Related Proteins in Chronic Lymphocytic Leukemia (CLL). (2004) (1)
Select high risk genetic features predict earlier progression following chemotherapy in chronic lymphocytic leukemia: Prospective randomized trial (Intergroup E2997) to evaluate justification for risk-adapted therapy. (2006) (1)
Molecular cytogenetics protocols and applications (2003) (1)
Short communication Loss of TP53 is due to rearrangements involving chromosome region 17p10~p12 in chronic lymphocytic leukemia (2006) (1)
Chromosome Study of Autopsy Tissues (2002) (1)
Critical Molecular Studies to Strategically Plan Therapy in Chronic Lymphocytic Leukemia (CLL): Correlating Cellular Proteins with Defined Prognostic Patient Subsets and Their Response to Treatment. (2004) (1)
Interphase Fluorescence In Situ Hybridization (FISH) with an IgH Probe Is Important in the Management of Patients with a Clinical Diagnosis of Chronic Lymphocytic Leukemia (CLL). (2004) (1)
Technical Advance A New Method to Extract Nuclei from Paraffin-Embedded Tissue to Study Lymphomas Using Interphase Fluorescence in Situ Hybridization (2002) (1)
Sister chromatid exchange. Progress and topics in cytogenetics, volume 2. Avery A. Sandberg (Ed.) New York: Alan R. Liss, Inc., 1982, 706 pp. $98.00 (1983) (0)
Submicroscopic Interstitial Deletions in 13q14 Are Detectable in Metaphase Cells by Fluorescence In Situ Hybridization (FISH) with D13S319 in Chronic Lymphocytic Leukemia (B-CLL). (2005) (0)
An unusual chromosome rearrangement in a patient with features of the Wolf-Hirschhorn syndrome. (1998) (0)
College News: AMERICAN COLLEGE OF MEDICAL GENETICS (2000) (0)
Autologous Hematopoietic Cell Transplantation as Consolidation for Younger Patients with Acute Myeloid Leukemia in First Complete Remission: Follow-up of E1900. (2009) (0)
Young Adults Presenting with Extramedullary Acute Myeloid Leukemia Have A Unique Sensitivity to High Doses of Anthracyclines: Subset Analysis of ECOG 1900, (2011) (0)
Abnormal marrow microenvironmental function in chronic myelogenous leukemia is related to the presence of malignant stromal macrophages (1994) (0)
NCCTG trial of gemcitabine for relapsed B-cell chronic lymphocytic leukemia (2004) (0)
A CYTOZOOO collaborative study (1999) (0)
Gregor Johann Mendel and the beginning of genetics. (1977) (0)
Natural history of patients with myelodysplastic syndromes (MDS) with interstitial deletions of chromosome 5q detected on G-banded karyotyping (2007) (0)
A Clinicopathologic Study of 107 (2015) (0)
Peripheral Blood Cytogenetic Studies in Myelofibrosis: Overall Yield and Comparison with Bone Marrow Cytogenetic Studies (2007) (0)
Deletions of 13ql4 in myeloma plasma cells usually represent large deletions of the q arm or monosomy (2000) (0)
Female phenotype andmultiple abnormalities in sibs with aY chromosome andpartial X chromosome duplication: H-Yantigen andXg blood groupfindings (1980) (0)
NCCTG trial of gemcitabine for relapsed B-cell chronic lymphocytic leukemia. (2004) (0)
Validation of CLL FISH Panel Scoring by Members of the Chronic Lymphocytic Leukemia Research Consortium. (2008) (0)
Chromosome Analysis of Autopsy Tissue (2009) (0)
The Authors’ Reply: A Matter of Semantics (1987) (0)
Ferrochelatase Mutation Screening by Denaturing High Performance Liquid Chomatography in Idiopathic Acquired Sideroblastic Anemia (Refractory Anemia with Ringed Sideroblasts) and Erythrocytic Protoporphyria. (2005) (0)
significance Genomic abnormalities in monoclonal gammopathy of undetermined (2013) (0)
Genes and cancer. UCLA symposia on molecular and cellular biology, New Series, Volume 17. J. Michael Bishop, Janet D. Rowley, and Mel Greaves, editors. Alan R. Liss, Inc.: New York, 1984, $88.00, 710pp (1987) (0)
89 consecutive patients with moderate to severe eosinophilia FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in (2013) (0)
Der(6)t(1;6)(q21-23;p21.3): The most specific chromosomal translocation in myelofibrosis with myeloid metaplasia (2005) (0)
myelodysplastic syndromes event in both ''atypical'' myeloproliferative disorders and The JAK2 V617F activating tyrosine kinase mutation is an infrequent (2013) (0)
Automated videodensitometry of human chromosomes. (1974) (0)
Reviewer Acknowledgment (2008) (0)
Chromosome analysis guidelines - preliminary report (2016) (0)
Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34) Defines a Very Poor Risk Leukemia Subgroup with Distinguishing Clinicopathological Features: A United States (US) Cytogenetics Intergroup Study of 62 AML and MDS Cases. (2004) (0)
Deletion 13q in B-CLL: Interphase FISH Reveals More 13q- Than Does CpG Stimulation. (2007) (0)
An infant with mosaic trisomy 16: Varying percentages of abnormal cells in different tissues (1992) (0)
Myeloma (mm) and the t(ll;14)(ql3;q32); increasing evidence for a biologically distinct subset of patients (2000) (0)
Utility of Interphase FISH To Stratify Patients into Cytogenetic Risk Categories at Diagnosis of AML in an ECOG Clinical Trial (E1900). (2005) (0)
Additional Cytogenetic Abnormalities and/or Philadelphia Chromosome Metaphase Mosaicism Might Adversely Influence Survival and Imatinib Response in Chronic Myeloid Leukemia. (2006) (0)
myeloid metaplasia Both B and T lymphocytes may be clonally involved in myelofibrosis with (2013) (0)
non-hyperdiploid variant multiple myeloma The recurrent IgH translocations are highly associated with (2013) (0)
Loss of p53 Is Due to Rearrangements in a ~6,400 kb Region of Low Copy Repeats near the Centromere of Chromosome 17 in Chronic Lymphocytic Leukemia (B-CLL). (2005) (0)
Low Incidence of FIP1L1-PDGFRA in Eosinophilic Patients and Long-Term Experience with Imatinib Therapy. (2005) (0)
Major differences with scoring karyotype results for patients with myelodysplastic syndromes using IPSS criteria: a call for international standardization (2008) (0)
Monosomal Karyotype (MK) In Older Patients with Acute Myeloid Leukemia (AML) on Eastern Cooperative Oncology Group (ECOG) Therapeutic Trials: Poor Prognostic Impact of MK, but Not of Monosomy 7 (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Gordon W. Dewald?

Gordon W. Dewald is affiliated with the following schools:

University of Minnesota

Gordon W. Dewald's Academic­Influence.com Rankings

Why Is Gordon W. Dewald Influential?

Gordon W. Dewald's Published Works

Published Works

What Schools Are Affiliated With Gordon W. Dewald?

Gordon W. Dewald's AcademicInfluence.com Rankings